FEB 24, 2021 3:26 PM PST

Inducing ferroptosis in neuroblastoma cells

New research published in the journal Cancer Research describes the process by which iron can trigger cell death in neuroblastoma cancer cells. The findings have implications for the development of future drugs that target the MYCN gene, which is overexpressed in 20-25% of neuroblastoma.

Neuroblastoma is a cancer of the nerve tissue seen most commonly in the glands around the kidneys. It affects mostly children ages five or younger. Researchers from VCU Massey Cancer Center are investigating how the MYCN gene is influenced by iron levels that cause ferroptosis, or cell death by way of iron accumulation.

"Iron is a double-edged sword in a cancer cell. It can help the cancer grow and survive, but it also creates these toxic molecules within the cell called reactive oxygen species," said Anthony Faber, Ph.D., who is an associate professor in the Philips Institute for Oral Health Research at the VCU School of Dentistry.

Due to their chemical instability, reactive oxygen species damage genes and can trigger cell death. Ferroptosis is one such form of cell death, but the scientific community is still trying to figure how to harness this iron-induced cell death for our benefit. The key to this is understanding how MYCN works.

"As MYCN continues to be one of the most important targets in cancer therapeutics, this study highlights a new and clinically important strategy for treating MYCN-associated cancers," Faber explained.

The scientists found that the MYCN gene is susceptible to drugs that induce ferroptosis because MYCN requires large amounts of iron to promote the cancer cell’s growth. The team plans to test the ability of FDA-approved drugs sulfasalazine and auronofin to induce ferroptosis and tumor responses in MYCN-amplified neuroblastoma cells.

The team will first test the drugs in patient-derived models and orthotopic models before moving on to clinical trials.

Sources: Cancer Research, Eureka Alert

About the Author
  • Kathryn is a curious world-traveller interested in the intersection between nature, culture, history, and people. She has worked for environmental education non-profits and is a Spanish/English interpreter.
You May Also Like
JAN 21, 2021
Cancer
Whole body MRI shown to be most sensitive in detecting myeloma
JAN 21, 2021
Whole body MRI shown to be most sensitive in detecting myeloma
New research suggests that whole body magnetic resonance imaging (WBMRI) is a more effective detection method than other ...
FEB 08, 2021
Microbiology
Fecal Transplants May Improve Cancer Treatment Efficacy
FEB 08, 2021
Fecal Transplants May Improve Cancer Treatment Efficacy
Humans carry around trillions of microbes, and the ones in our guts - the gut microbiome - plays an essential role in ou ...
MAR 02, 2021
Cell & Molecular Biology
Koala Retrovirus Can Rewrite the Genome & Trigger Cancer
MAR 02, 2021
Koala Retrovirus Can Rewrite the Genome & Trigger Cancer
Retroviruses can infect cells and insert themselves into the genetic code of their host. Sometime in the past 50,000 yea ...
MAR 02, 2021
Cancer
New tissue restoration technology could help breast cancer patients
MAR 02, 2021
New tissue restoration technology could help breast cancer patients
New work published in Scientific Reports describes the development of an in situ scaffold-forming collagen that cou ...
MAR 03, 2021
Cancer
Multiple breast cancer screenings reduce mortality rates
MAR 03, 2021
Multiple breast cancer screenings reduce mortality rates
New research published in the journal Radiology reports on the advantages that multiple breast cancer screenings can hav ...
APR 01, 2021
Immunology
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
APR 01, 2021
Tumor-Killing 101: Vaccine Trains Immune Cells to Keep Skin Cancer at Bay
Cancer researchers have developed a therapeutic vaccine for melanoma, a deadly form of skin cancer. Instead of protectin ...
Loading Comments...